Literature DB >> 17531397

The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry.

Eng-Yen Huang1, Chien-Cheng Sung, Sheung-Fat Ko, Chong-Jong Wang, Kuender D Yang.   

Abstract

PURPOSE: To evaluate the effect of abdominal surgery on the volume effects of small-bowel toxicity during whole-pelvic irradiation in patients with gynecologic malignancies. METHODS AND MATERIALS: From May 2003 through November 2006, 80 gynecologic patients without (Group I) or with (Group II) prior abdominal surgery were analyzed. We used a computed tomography (CT) planning system to measure the small-bowel volume and dosimetry. We acquired the range of small-bowel volume in 10% (V10) to 100% (V100) of dose, at 10% intervals. The onset and grade of diarrhea during whole-pelvic irradiation were recorded as small-bowel toxicity up to 39.6 Gy in 22 fractions.
RESULTS: The volume effect of Grade 2-3 diarrhea existed from V10 to V100 in Group I patients and from V60 to V100 in Group II patients on univariate analyses. The V40 of Group I and the V100 of Group II achieved most statistical significance. The mean V40 was 281 +/- 27 cm(3) and 489 +/- 34 cm(3) (p < 0.001) in Group I patients with Grade 0-1 and Grade 2-3 diarrhea, respectively. The corresponding mean V100 of Group II patients was 56 +/- 14 cm(3) and 132 +/- 19 cm(3) (p = 0.003). Multivariate analyses revealed that V40 (p = 0.001) and V100 (p = 0.027) were independent factors for the development of Grade 2-3 diarrhea in Groups I and II, respectively.
CONCLUSIONS: Gynecologic patients without and with abdominal surgery have different volume effects on small-bowel toxicity during whole-pelvic irradiation. Low-dose volume can be used as a predictive index of Grade 2 or greater diarrhea in patients without abdominal surgery. Full-dose volume is more important than low-dose volume for Grade 2 or greater diarrhea in patients with abdominal surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17531397     DOI: 10.1016/j.ijrobp.2007.03.060

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms.

Authors:  R A Schneider; V Vitolo; F Albertini; T Koch; C Ares; A Lomax; G Goitein; E B Hug
Journal:  Strahlenther Onkol       Date:  2013-09-21       Impact factor: 3.621

Review 2.  Technical aspects of radiation therapy for anal cancer.

Authors:  Eli D Scher; Inaya Ahmed; Ning J Yue; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer.

Authors:  T Jonathan Yang; Jung Hun Oh; Christina H Son; Aditya Apte; Joseph O Deasy; Abraham Wu; Karyn A Goodman
Journal:  Gastrointest Cancer Res       Date:  2013-09

4.  Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning.

Authors:  Carmen Stromberger; Yves Kom; Michael Kawgan-Kagan; Tristan Mensing; Ulrich Jahn; Achim Schneider; Volker Budach; Christhardt Köhler; Simone Marnitz
Journal:  Radiat Oncol       Date:  2010-07-02       Impact factor: 3.481

Review 5.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

6.  The different dose-volume effects of normal tissue complication probability using LASSO for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery.

Authors:  Tsair-Fwu Lee; Eng-Yen Huang
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

7.  Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation.

Authors:  Eng-Yen Huang; Feng-Sheng Wang; Yu-Min Chen; Yi-Fan Chen; Chung-Chi Wang; I-Hui Lin; Yu-Jie Huang; Kuender D Yang
Journal:  Oncotarget       Date:  2014-10-30

8.  Effect of different treatment plans on irradiated small-bowel volume in gynecologic patients undergoing whole-pelvic irradiation.

Authors:  Shih-Chen Chang; Hsiao-Fei Lee; Hui-Min Ting; Tzu-Chao Pan; Shu-Yu Liu; Chien-Fu Chen; Teng-Yi Wang; Kuo-Jung Juan; Tsung-I Liao; Eng-Yen Huang
Journal:  J Radiat Res       Date:  2013-03-27       Impact factor: 2.724

9.  Late small bowel toxicity after aggressive abdominopelvic intensity modulated radiation therapy.

Authors:  Andrew Ling; Eli Furhang; Shannon N Ryemon; Ronald D Ennis
Journal:  Adv Radiat Oncol       Date:  2017-09-08

10.  Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer.

Authors:  Siyuan Li; Yanping Gong; Yongqiang Yang; Qi Guo; Jianjun Qian; Ye Tian
Journal:  Radiat Oncol       Date:  2020-09-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.